Blab Business
KKR Acquires Medicover India Hospital Network in 10,000-Crore Deal
On Thursday, global private‑equity giant KKR & Co. announced a ₹10,000‑crore purchase of Medicover AB’s Indian hospital arm, a move that signals a fresh wave of consolidation in the country’s private‑care sector. The deal, first reported by the Economic Times and later covered by Reuters and Bloomberg, values the Medicover India network at roughly ₹10,000 crore (about $1.4‑$1.5 billion). In addition to the purchase price, KKR is expected to provide primary capital of ₹3,000‑4,000 crore (≈$400‑$500 million) to support the company’s expansion plans.
Medicover India operates 24 multi‑specialty hospitals across South and West India, with a total bed capacity of about 4,800 and a workforce of more than 1,900 doctors. The network offers care in over 80 clinical specialties. The hospitals are managed through Sahrudaya HealthCare Pvt. Ltd. (SHPL), a company that Medicover entered India through in 2017 by acquiring a controlling stake in Hyderabad‑based Sahrudaya Healthcare, the operator of the MaxCure chain. Medicover Holdings B.V. holds a 67% stake in SHPL, while the remaining shares are owned by founding doctors and senior management.
Financially, Medicover India reported revenue of $217.25 million for fiscal year 2025, a 14% year‑on‑year increase. EBITDA was $25.68 million, giving a margin of 11.8%. The company posted a net loss of $23.69 million, according to Tracxn data. Cardiology and neurology accounted for 34% of the network’s in‑patient revenue in FY25, and the company plans to broaden its specialty mix by adding oncology and other services.
KKR’s spokesperson, Akshay Tanna, Head of India Private Equity, said the firm is “looking forward to contributing to its next phase by investing behind its talent, technology, infrastructure and clinical capabilities, while reinforcing strong clinical governance and operational standards.” The investment is part of KKR’s broader strategy to build a regional healthcare platform in India, following earlier acquisitions such as a 70% stake in Kerala‑based Baby Memorial Hospital for about $300 million in 2025.
Since 2004, KKR has invested more than $20 billion in the global healthcare ecosystem. The firm’s recent activity in India includes the acquisition of Baby Memorial Hospital, the purchase of a controlling stake in oncology‑focused Healthcare Global Enterprises, and a $600 million financing for Manipal Education and Medical Group. These moves reflect growing investor interest in India’s healthcare sector, driven by rising demand for quality care, expanding health‑insurance penetration, and opportunities to scale regional hospital networks.
The deal is expected to close in the fourth quarter of 2026, subject to customary regulatory approvals and other closing conditions. Medicover AB will retain its European operations, while the Indian business will be integrated into KKR’s portfolio of healthcare assets.
The acquisition underscores the continued consolidation of India’s private hospital market and the increasing role of global private‑equity investors in shaping the sector’s future.
Medicover India operates 24 multi‑specialty hospitals across South and West India, with a total bed capacity of about 4,800 and a workforce of more than 1,900 doctors. The network offers care in over 80 clinical specialties. The hospitals are managed through Sahrudaya HealthCare Pvt. Ltd. (SHPL), a company that Medicover entered India through in 2017 by acquiring a controlling stake in Hyderabad‑based Sahrudaya Healthcare, the operator of the MaxCure chain. Medicover Holdings B.V. holds a 67% stake in SHPL, while the remaining shares are owned by founding doctors and senior management.
Financially, Medicover India reported revenue of $217.25 million for fiscal year 2025, a 14% year‑on‑year increase. EBITDA was $25.68 million, giving a margin of 11.8%. The company posted a net loss of $23.69 million, according to Tracxn data. Cardiology and neurology accounted for 34% of the network’s in‑patient revenue in FY25, and the company plans to broaden its specialty mix by adding oncology and other services.
KKR’s spokesperson, Akshay Tanna, Head of India Private Equity, said the firm is “looking forward to contributing to its next phase by investing behind its talent, technology, infrastructure and clinical capabilities, while reinforcing strong clinical governance and operational standards.” The investment is part of KKR’s broader strategy to build a regional healthcare platform in India, following earlier acquisitions such as a 70% stake in Kerala‑based Baby Memorial Hospital for about $300 million in 2025.
Since 2004, KKR has invested more than $20 billion in the global healthcare ecosystem. The firm’s recent activity in India includes the acquisition of Baby Memorial Hospital, the purchase of a controlling stake in oncology‑focused Healthcare Global Enterprises, and a $600 million financing for Manipal Education and Medical Group. These moves reflect growing investor interest in India’s healthcare sector, driven by rising demand for quality care, expanding health‑insurance penetration, and opportunities to scale regional hospital networks.
The deal is expected to close in the fourth quarter of 2026, subject to customary regulatory approvals and other closing conditions. Medicover AB will retain its European operations, while the Indian business will be integrated into KKR’s portfolio of healthcare assets.
The acquisition underscores the continued consolidation of India’s private hospital market and the increasing role of global private‑equity investors in shaping the sector’s future.
